Molecular electronic tuning of photosensitizers to enhance photodynamic therapy: synthetic dicyanobacteriochlorins as a case study.
Molecular electronic tuning of photosensitizers to enhance photodynamic therapy: synthetic dicyanobacteriochlorins as a case study.
复制标题
DOI:
10.1111/php.12021
复制
发表时间:
2013-05
影响因子:
3.3
通讯作者:
Holten D
中科院分区:
文献类型:
--
作者:
Yang E;Diers JR;Huang YY;Hamblin MR;Lindsey JS;Bocian DF;Holten D
Photophysical, photostability, electrochemical, and molecular-orbital characteristics are analyzed for a set of stable dicyanobacteriochlorins that are promising photosensitizers for photodynamic therapy (PDT). The bacteriochlorins are the parent compound (BC), dicyano derivative (NC)2BC and corresponding zinc (NC)2BC-Zn and palladium chelate (NC)2BC-Pd. The order of PDT activity against HeLa human cancer cells in vitro is (NC)2BC-Pd > (NC)2BC > (NC)2BC-Zn ≈ BC. The near-infrared absorption feature of each dicyanobacteriochlorin is bathochromically shifted 35–50 nm (748–763 nm) from that for BC (713 nm). Intersystem crossing to the PDT-active triplet excited state is essentially quantitative for (NC)2BC-Pd. Phosphorescence from (NC)2BC-Pd occurs at 1122 nm (1.1 eV). This value and the measured ground-state redox potentials fix the triplet excited-state redox properties, which underpin PDT activity via Type-1 (electron-transfer) pathways. A perhaps counterintuitive (but readily explicable) result is that of the three dicyanobacteriochlorins, the photosensitizer with the shortest triplet lifetime (7 μs), (NC)2BC-Pd, has the highest activity. Photostabilities of the dicyanobacteriochlorins and other bacteriochlorins studied recently are investigated and discussed in terms of four phenomena: aggregation, reduction, oxidation, and chemical reaction. Collectively, the results and analysis provide fundamental insights concerning the molecular design of PDT agents.
登录
查看更多内容
影响因子:
7.3
作者:
Huang, Ying-Ying;Mroz, Pawel;Zhiyentayev, Timur;Sharma, Sulbha K.;Balasubramanian, Thiagarajan;Ruzie, Christian;Krayer, Michael;Fan, Dazhong;Borbas, K. Eszter;Yang, Eunkyung;Kee, Hooi Ling;Kirmaier, Christine;Diers, James R.;Bocian, David F.;Holten, Dewey;Lindsey, Jonathan S.;Hamblin, Michael R.
通讯作者:
Hamblin, Michael R.
DOI:
10.3322/caac.20114
发表时间:
2011-07
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Agostinis P;Berg K;Cengel KA;Foster TH;Girotti AW;Gollnick SO;Hahn SM;Hamblin MR;Juzeniene A;Kessel D;Korbelik M;Moan J;Mroz P;Nowis D;Piette J;Wilson BC;Golab J
通讯作者:
Golab J
影响因子:
4.9
作者:
Huang, Liyi;Huang, Ying-Ying;Hamblin, Michael R.
通讯作者:
Hamblin, Michael R.
影响因子:
3.3
作者:
Mass, Olga;Taniguchi, Masahiko;Lindsey, Jonathan S.
通讯作者:
Lindsey, Jonathan S.
影响因子:
4.8
作者:
Mroz, Pawel;Huang, Ying-Ying;Hamblin, Michael R.
通讯作者:
Hamblin, Michael R.